Acute Myeloid Leukemia (MLL Rearrangement): Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of 67 Year old female presented with painful nodular skin lesions mainly involving the face and the extremities of 6 weeks duration. FISH studies identified the MLLT4-MLL rearrangement in 94% of analyzed nuclei.  Molecular studies for FLT3, NPM1 and CEBPA were negative.

Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim a CME, completion, or participation certificate for completing this activity. 

Learning Objectives

  • Determine the differential diagnosis of skin rashes that precede or accompany a diagnosis of acute myeloid leukemia (AML)
  • Evaluate the prognostic significance of the MLL gene rearrangement in AML
  • Analyze the role of molecular testing (next generation sequencing and RNA sequencing) in prognostication and therapeutics of patients with AML

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on September 23, 2018. Participants must complete all necessary course components by this date to receive credit.